+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

10-Deacetylbaccatine III global market

10-Deacetylbaccatine III global market

Global 10-Deacetylbaccatine III Market Research Report 2025

This report on the global 10-deacetylbaccatine iii market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends, regio

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global 10-Deacetylbaccatine III Market Report (2025–2035)

Market Outlook

Chem Reports projects that the 10-Deacetylbaccatine III Market was valued at USD xxxx million in 2024 and is expected to reach USD xxxx million by 2035, growing at a CAGR of xx% globally.

Global Market Overview

The Global 10-Deacetylbaccatine III Market Report 2020 provides an extensive analysis of industry development drivers, patterns, flows, and market size. Historical and present values are assessed to forecast market performance through 2025–2035. The study integrates both primary and secondary data sources, examining:

  • Government policies and regulatory environment
  • Competitive landscape and market structure
  • Historical data and current market trends
  • Technological innovation and upcoming advancements
  • Industry progress in related sectors

Impact of COVID-19

The outbreak of COVID-19 in late 2019 disrupted global supply chains and demand patterns. The 10-Deacetylbaccatine III market experienced significant challenges in 2020, with long-term effects on production, distribution, and consumption trends.

Market Segmentation

By Type

  • ≥95%
  • ≥98.0%
  • Others

By Application

  • Production of Docetaxel
  • Production of Paclitaxel
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in pharmaceutical manufacturing.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by advanced drug development and strict regulatory standards.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by pharmaceutical expansion and increasing cancer treatment demand.
  • South America (Brazil, Argentina): Emerging opportunities in oncology drug production.
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and healthcare modernization.

Key Players

  • SM Herbals
  • Alchem International
  • Indena
  • South Pharmaceutical
  • HAOXUAN
  • Yuannan Hande
  • Sai Phytoceuticals
  • Sarv Biolabs Pvt
  • Aphios
  • Hainan Yew Pharmaceutical

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in oncology drug manufacturing, particularly for Docetaxel and Paclitaxel.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by advanced pharmaceutical R&D and strict regulatory standards.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by pharmaceutical expansion, rising cancer incidence, and cost-effective manufacturing hubs.
  • South America (Brazil, Argentina): Emerging opportunities in oncology drug production and imports of active pharmaceutical ingredients (APIs).
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and healthcare modernization initiatives.

Detailed Segmentation Analysis

By Type

  • ≥95% Purity: Used in intermediate pharmaceutical processes.
  • ≥98.0% Purity: Preferred for high-quality oncology drug production.
  • Others: Specialty grades for research and niche applications.

By Application

  • Production of Docetaxel: Largest segment, driven by demand for chemotherapy drugs.
  • Production of Paclitaxel: Strong demand in oncology treatments.
  • Others: Specialty uses in research and experimental therapies.

Porter’s Five Forces

  1. Competitive Rivalry: High; global pharmaceutical ingredient suppliers compete in oncology drug intermediates.
  2. Threat of New Entrants: Moderate; barriers include regulatory approvals, R&D costs, and specialized extraction processes.
  3. Bargaining Power of Suppliers: Moderate; raw material sourcing (yew trees and semi-synthetic processes) influences costs.
  4. Bargaining Power of Buyers: High; pharmaceutical companies demand purity, consistency, and competitive pricing.
  5. Threat of Substitutes: Moderate; alternatives include synthetic intermediates and other taxane derivatives.

SWOT Analysis

Strengths

  • Critical intermediate for blockbuster oncology drugs (Docetaxel, Paclitaxel)
  • Strong alignment with global cancer treatment demand
  • Established supply chains with specialized pharmaceutical companies

Weaknesses

  • High production costs and dependence on natural sources
  • Regulatory scrutiny in pharmaceutical manufacturing
  • Limited awareness outside oncology drug development

Opportunities

  • Expansion into emerging pharmaceutical markets
  • Innovation in semi-synthetic and biotechnological production methods
  • Rising demand for oncology drugs globally

Threats

  • Competition from alternative synthetic intermediates
  • Volatile raw material supply (yew tree derivatives)
  • Stringent regulatory frameworks in developed markets

Trend Analysis

  • Rising demand for oncology drugs worldwide
  • Increasing focus on semi-synthetic and biotechnological production methods
  • Growth in Asia-Pacific pharmaceutical manufacturing hubs
  • Technological advancements in extraction and purification processes

Drivers & Challenges

Drivers

  • Expanding oncology drug market
  • Rising global cancer incidence
  • Technological innovation in pharmaceutical intermediates

Challenges

  • Environmental and regulatory pressures on natural sourcing
  • High production costs compared to synthetic alternatives
  • Supply chain volatility for raw materials

Value Chain Analysis

  • Upstream: Yew tree cultivation and raw material suppliers
  • Midstream: Extraction and processing companies (SM Herbals, Alchem International, Indena, Yuannan Hande, etc.)
  • Downstream: End-users in pharmaceutical companies producing Docetaxel and Paclitaxel
  • Support Activities: Logistics, certification, regulatory compliance, R&D innovation

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in semi-synthetic and biotechnological production methods to reduce dependence on natural sources.
  • Distributors: Expand networks in Asia-Pacific and South America to leverage high-growth pharmaceutical markets.
  • Investors: Focus on companies innovating in oncology intermediates and securing long-term pharmaceutical contracts.
  • Policy Makers: Support sustainable sourcing practices and incentivize biotechnological innovation.
  • End-users (pharmaceutical companies): Secure diversified supply chains and adopt advanced purification methods to ensure quality and compliance.

Explore more reports here-

https://chemreports.com/reports

 

1. Market Overview of 10-Deacetylbaccatine III Market
    1.1 10-Deacetylbaccatine III Market Market Overview
        1.1.1 10-Deacetylbaccatine III Market Product Scope
        1.1.2 Market Status and Outlook
    1.2 10-Deacetylbaccatine III Market Market Size by Regions:
    1.3 10-Deacetylbaccatine III Market Historic Market Size by Regions
    1.4 10-Deacetylbaccatine III Market Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact 10-Deacetylbaccatine III Market Sales Market by Type
    2.1 Global 10-Deacetylbaccatine III Market Historic Market Size by Type
    2.2 Global 10-Deacetylbaccatine III Market Forecasted Market Size by Type
    2.3 ?95%
    2.4 ?98.0%
    2.5 Others
3. Covid-19 Impact 10-Deacetylbaccatine III Market Sales Market by Application
    3.1 Global 10-Deacetylbaccatine III Market Historic Market Size by Application
    3.2 Global 10-Deacetylbaccatine III Market Forecasted Market Size by Application
    3.3 Production of Docetaxel
    3.4 Production of Paclitaxel
    3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global 10-Deacetylbaccatine III Market Production Capacity Market Share by Manufacturers
    4.2 Global 10-Deacetylbaccatine III Market Revenue Market Share by Manufacturers
    4.3 Global 10-Deacetylbaccatine III Market Average Price by Manufacturers
5. Company Profiles and Key Figures in 10-Deacetylbaccatine III Market Business
    5.1 SM Herbals
        5.1.1 SM Herbals Company Profile
        5.1.2 SM Herbals 10-Deacetylbaccatine III Market Product Specification
        5.1.3 SM Herbals 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.2 Alchem International
        5.2.1 Alchem International Company Profile
        5.2.2 Alchem International 10-Deacetylbaccatine III Market Product Specification
        5.2.3 Alchem International 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.3 Indena
        5.3.1 Indena Company Profile
        5.3.2 Indena 10-Deacetylbaccatine III Market Product Specification
        5.3.3 Indena 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.4 South Pharmaceutical
        5.4.1 South Pharmaceutical Company Profile
        5.4.2 South Pharmaceutical 10-Deacetylbaccatine III Market Product Specification
        5.4.3 South Pharmaceutical 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.5 HAOXUAN
        5.5.1 HAOXUAN Company Profile
        5.5.2 HAOXUAN 10-Deacetylbaccatine III Market Product Specification
        5.5.3 HAOXUAN 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.6 Yuannan Hande
        5.6.1 Yuannan Hande Company Profile
        5.6.2 Yuannan Hande 10-Deacetylbaccatine III Market Product Specification
        5.6.3 Yuannan Hande 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.7 Sai Phytoceuticals
        5.7.1 Sai Phytoceuticals Company Profile
        5.7.2 Sai Phytoceuticals 10-Deacetylbaccatine III Market Product Specification
        5.7.3 Sai Phytoceuticals 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.8 Sarv Biolabs Pvt
        5.8.1 Sarv Biolabs Pvt Company Profile
        5.8.2 Sarv Biolabs Pvt 10-Deacetylbaccatine III Market Product Specification
        5.8.3 Sarv Biolabs Pvt 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.9 Aphios
        5.9.1 Aphios Company Profile
        5.9.2 Aphios 10-Deacetylbaccatine III Market Product Specification
        5.9.3 Aphios 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
    5.10 Hainan Yew Pharmaceutical
        5.10.1 Hainan Yew Pharmaceutical Company Profile
        5.10.2 Hainan Yew Pharmaceutical 10-Deacetylbaccatine III Market Product Specification
        5.10.3 Hainan Yew Pharmaceutical 10-Deacetylbaccatine III Market Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America 10-Deacetylbaccatine III Market Market Size
    6.2 North America 10-Deacetylbaccatine III Market Key Players in North America
    6.3 North America 10-Deacetylbaccatine III Market Market Size by Type
    6.4 North America 10-Deacetylbaccatine III Market Market Size by Application
7. East Asia
    7.1 East Asia 10-Deacetylbaccatine III Market Market Size
    7.2 East Asia 10-Deacetylbaccatine III Market Key Players in North America
    7.3 East Asia 10-Deacetylbaccatine III Market Market Size by Type
    7.4 East Asia 10-Deacetylbaccatine III Market Market Size by Application
8. Europe
    8.1 Europe 10-Deacetylbaccatine III Market Market Size
    8.2 Europe 10-Deacetylbaccatine III Market Key Players in North America
    8.3 Europe 10-Deacetylbaccatine III Market Market Size by Type
    8.4 Europe 10-Deacetylbaccatine III Market Market Size by Application
9. South Asia
    9.1 South Asia 10-Deacetylbaccatine III Market Market Size
    9.2 South Asia 10-Deacetylbaccatine III Market Key Players in North America
    9.3 South Asia 10-Deacetylbaccatine III Market Market Size by Type
    9.4 South Asia 10-Deacetylbaccatine III Market Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia 10-Deacetylbaccatine III Market Market Size
    10.2 Southeast Asia 10-Deacetylbaccatine III Market Key Players in North America
    10.3 Southeast Asia 10-Deacetylbaccatine III Market Market Size by Type
    10.4 Southeast Asia 10-Deacetylbaccatine III Market Market Size by Application
11. Middle East
    11.1 Middle East 10-Deacetylbaccatine III Market Market Size
    11.2 Middle East 10-Deacetylbaccatine III Market Key Players in North America
    11.3 Middle East 10-Deacetylbaccatine III Market Market Size by Type
    11.4 Middle East 10-Deacetylbaccatine III Market Market Size by Application
12. Africa
    12.1 Africa 10-Deacetylbaccatine III Market Market Size
    12.2 Africa 10-Deacetylbaccatine III Market Key Players in North America
    12.3 Africa 10-Deacetylbaccatine III Market Market Size by Type
    12.4 Africa 10-Deacetylbaccatine III Market Market Size by Application
13. Oceania
    13.1 Oceania 10-Deacetylbaccatine III Market Market Size
    13.2 Oceania 10-Deacetylbaccatine III Market Key Players in North America
    13.3 Oceania 10-Deacetylbaccatine III Market Market Size by Type
    13.4 Oceania 10-Deacetylbaccatine III Market Market Size by Application
14. South America
    14.1 South America 10-Deacetylbaccatine III Market Market Size
    14.2 South America 10-Deacetylbaccatine III Market Key Players in North America
    14.3 South America 10-Deacetylbaccatine III Market Market Size by Type
    14.4 South America 10-Deacetylbaccatine III Market Market Size by Application
15. Rest of the World
    15.1 Rest of the World 10-Deacetylbaccatine III Market Market Size
    15.2 Rest of the World 10-Deacetylbaccatine III Market Key Players in North America
    15.3 Rest of the World 10-Deacetylbaccatine III Market Market Size by Type
    15.4 Rest of the World 10-Deacetylbaccatine III Market Market Size by Application
16 10-Deacetylbaccatine III Market Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • ≥95%
  • ≥98.0%
  • Others

By Application

  • Production of Docetaxel
  • Production of Paclitaxel
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico): Mature market with strong demand in pharmaceutical manufacturing.
  • Europe (Germany, U.K., France, Italy, Spain, Russia): Stable demand, shaped by advanced drug development and strict regulatory standards.
  • Asia-Pacific (China, India, Japan, Southeast Asia): Fastest-growing region, driven by pharmaceutical expansion and increasing cancer treatment demand.
  • South America (Brazil, Argentina): Emerging opportunities in oncology drug production.
  • Middle East & Africa (Saudi Arabia, South Africa): Growing demand supported by imports and healthcare modernization.

Key Players

  • SM Herbals
  • Alchem International
  • Indena
  • South Pharmaceutical
  • HAOXUAN
  • Yuannan Hande
  • Sai Phytoceuticals
  • Sarv Biolabs Pvt
  • Aphios
  • Hainan Yew Pharmaceutical

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.